The Penicillins and Streptomycins dosage market in Kyrgyzstan showed fluctuating performance over the past decade, with the market size valuing 10.516 million USD in 2023. A notable growth was seen in 2018 and 2021, followed by declines, particularly significant in 2022 with a year-on-year decrease of 9.46%. The Compound Annual Growth Rate (CAGR) over the last five years was -0.84%, indicating a general contraction. The most recent figures from 2023 represent a slight decrease of 0.4% compared to the previous year.
Future trends to watch for:
- Potential regulatory changes impacting market dynamics.
- Innovations in antibiotic formulations and alternatives potentially affecting demand.
- Economic developments within Kyrgyzstan influencing healthcare expenditure priorities.
- Global and regional health initiatives pressuring or supporting antibiotic usage.
How does Kyrgyzstan rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 27 | 27 Ghana | 19,904,000 | 2023 | +0.28% | -1.55% | View data |
| 28 | 28 Nicaragua | 15,976,000 | 2023 | -0.12% | +0.75% | View data |
| 29 | 29 Kyrgyzstan | 10,516,000 | 2023 | -0.4% | -0.84% | |
| 30 | 30 Moldova | 5,776,600 | 2023 | -4.38% | -6.74% | View data |
| 31 | 31 Armenia | 5,084,600 | 2023 | -2.21% | -0.94% | View data |
